Tumor gene mutation detection kit tender: what is the price difference between domestic and imported products?

When comparing prices, you must factor in the supporting costs. Some domestic quotes are cheaper but do not include extraction reagents, calibrators, positive and negative controls, or analysis software, while imported quotes are higher but come with a complete set of supporting components and more training support. In addition, check whether the local reimbursement code supports the project and whether the kit has matching medical insurance/pricing access and external quality assessment programs. It is recommended to invite 2-3 shortlisted manufacturers to conduct preliminary experiments using the same batch of clinical samples or standards, comparing detection rates, operating time, ease of result interpretation, and after-sales response. Ultimately, do not award the contract based on price alone; set batch-to-batch variation, supply stability, and technical support response time as scoring items, otherwise the laboratory will face significant risk when changing batches later.

The actual transaction price is difficult to give as a direct figure because provincial centralized procurement, hospital price negotiations, distributor markups, reagent specifications, and the number of tests all vary. For imported and domestic qPCR multi-gene mutation reagent kits, the price difference per test can be substantial; sometimes imported products are several times more expensive than domestic ones, but after price reductions, imported products may also come close. It is recommended that during tendering, you not only look at the total quotation but also examine the cost per test or per person, and require suppliers to provide supply invoices or bid-winning notices from other hospitals in the same region as supporting evidence. Focus on verifying whether the quotation includes all loci such as EGFR, ALK, ROS1, and BRAF, as well as positive and negative controls and enzyme master mix, to avoid additional charges being added later.

It is understandable to worry about lot-to-lot variability in domestic products, but imported products also have batch-to-batch differences. It is recommended to include lot-to-lot consistency in the tender technical specifications: require three batches of kits to be tested against the same panel of weak-positive, negative, and positive standards, and require the Ct value CV and the concordance rate for positive/negative results to meet your preset criteria. You may require the manufacturer to come to the hospital for performance verification, or provide third-party external quality assessment sample results. Regarding supply lead time, domestic routine qPCR kits are mostly in stock and generally arrive in 1-4 weeks; for imported products, if stock is available in a domestic bonded warehouse, it may take 2-4 weeks, and if not, it is necessary to wait for the original manufacturer's production scheduling and cold-chain customs clearance, which may take 4-8 weeks. When requesting quotations, have suppliers quote both in-stock and forward delivery prices as well as the minimum order quantity at the same time.